(San Francisco, CA) — In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two …
Chicago, November 23, 2010 — Results of the world’s first efficacy trial of an HIV-prevention approach called oral pre-exposure prophylaxis, or PrEP, were released online in the New England Journal of Medicine today. Data from this trial, called i…
The use of the antidepressant, sustained release (SR) bupropion, triples quit rates among women and smokers with a history of depression as compared to placebo, according to a new study just published in Nicotine and Tobacco Research by researchers at the Center for Tobacco Research and Intervention. Historically, women and formerly depressed smokers are at particularly high risk of relapse.